SynCardia Systems has announced that more than 20 SynCardia certified centres representing four countries and more than 70 authors will present a record number of abstracts discussing the SynCardia temporary Total Artificial Heart at the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT; Montreal, Canada, 24–27 April).
Maquet Cardiovascular LLC (Wayne, NJ) announced that it has received the US Food and Drug Administration’s 510(k) clearance and European CE Mark approval for the Air-Band radial compression device. The Air-Band device is indicated to assist hemostasis of the radial artery after a transradial procedure. It is designed to compress the radial artery puncture site while maintaining site visibility and a secure fit around the wrist. The Air-Band radial compression device is now commercially available in Europe and will be launched in the United States later this month.
Como una forma de respaldar la recomendación de consumir un par de porciones de pescado por semana, un estudio sugiere que los adultos con más ácidos grasos omega 3 en sangre serían menos propensos a morir por distintas causas.
Caminar a paso vivo es igual de bueno que correr para reducir la presión arterial, el colesterol y el riesgo de diabetes, tres factores importantes en el desarrollo de la enfermedad cardiaca, halla un estudio reciente.
Una nueva investigación japonesa muestra un vínculo potencial entre la calvicie masculina y un mayor riesgo de enfermedad cardiaca coronaria. Pero solo afecta a los hombres que se están quedando calvos en la coronilla. Los que tienen calvicie inicial en la línea del cabello no están en riesgo, reportaron los investigadores.
A study published ahead of print in the Journal of the American College of Cardiology indicates that following implantation of a left ventricular assist device (LVAD), sexual function does not improve and may even worsen—with LVAD equipment frequently cited as an obstacle to sexual function.
Una prueba experimental de la respiración, diseñada para detectar rápidamente a aquellos pacientes que sufren de insuficiencia cardiaca simplemente al analizar el contenido de un solo aliento exhalado, ha dado muestras de ser prometedora en los ensayos preliminares, afirma un equipo de investigadores.
The PARTNER cohort A study, which compared transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement in high-risk patients with severe aortic stenosis, found that after three years, the valve did not show any signs of structural deterioration and that TAVI is comparable to surgery.
ORBIT III, which was presented at the recent ACC meeting, met its primary endpoint and showed that the Orbital atherectomy system (Cardiovascular Systems) was associated with an 89.8% freedom from major adverse cardiovascular events (MACE) rate and a procedural success rate of 89.1% (including in-hospital MACE).
Boston Scientific has announced that, for the first time in the world, its next generation Promus Premier everolimus-eluting stent has been implanted (at centres in Ireland and The Netherlands) in patients with coronary artery disease.
According to a new study published ahead-of-print in the Journal of Thoracic and Cardiovascular Surgery, St Jude Medical’s Trifecta aortic valve has a similar haemodynamic performance to that of a healthy aortic valve and is “easy to implant”.
Abbott Vascular has announced that the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted five to three that the benefits of its MitraClip system for the management of mitral regurgitation outweigh its risks. However, the panel also voted five to four that there was not a reasonable assurance of the device’s efficacy.
Boston Scientific has announced that the Platinum China study, which was presented at China Interventional Therapeutics (20–23 March, Beijing, China), indicated that the Promus Element stent is associated with a low rate of stent thrombosis at nine months. These data support the existing safety and efficacy data for the stent.
Pero se necesita más investigación sobre las bebidas ricas en cafeína, según una revisión
Los resultados sorprenden y decepcionan a los científicos
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos